Brian Adams

CIK 1636994 · Chief Legal Officer · last filed 2026-03-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.65M

Companies

3

Total Filings

74

Lifetime Open-Market Net

-$2.08M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KYMR Chief Legal Officer 56,625 $86.20 $4.88M $0 2 2026-03-04
RLAY Chief Legal Officer 389,748 $14.81 $5.77M -$1.82M 45 2025-07-30
KERYX BIOPHARMACEUTICALS INC (KERX) Delisted General Counsel and Secretary 126,069 -$262.5K 27 2018-02-16

Recent Filings · Page 5 of 8

74 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-30 RLAY Sell (S) −293 -$10.5K EDGAR
2021-06-09 RLAY Mixed -$200.7K EDGAR
2021-04-28 RLAY Mixed -$200.7K EDGAR
2021-03-26 RLAY Grant (A) +15,870 $0 EDGAR
2021-01-29 RLAY Mixed -$254.7K EDGAR
2020-12-15 RLAY Grant (A) $0 EDGAR
2020-07-21 RLAY Buy (P) +10,000 $200.0K EDGAR
2018-02-16 KERYX BIOPHARMACEUTICALS INC (KERX) Delisted Sell (S) −5,652 -$27.2K EDGAR
2018-01-31 KERYX BIOPHARMACEUTICALS INC (KERX) Delisted Sell (S) −1,541 -$7.4K EDGAR
2018-01-08 KERYX BIOPHARMACEUTICALS INC (KERX) Delisted Sell (S) −753 -$3.5K EDGAR
Showing 4150 of 74
Page 5 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.